Glory Health Industry Valuation
Is 84R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 84R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 84R's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 84R's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 84R?
Key metric: As 84R is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 84R's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | CN¥2.04b |
| Market Cap | CN¥550.19m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 12.3x |
| Enterprise Value/EBITDA | -275.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 84R's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.1x | ||
CRZK CR Energy | 8.1x | 39.0% | €123.7m |
ZYW China Properties Group | 3.1x | n/a | €66.9m |
2GI GIEAG Immobilien | 0.9x | n/a | €14.0m |
NUVA Noratis | 0.3x | 16.6% | €15.2m |
84R Glory Health Industry | 0.3x | n/a | €591.1m |
Price-To-Sales vs Peers: 84R is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (3.1x).
Price to Sales Ratio vs Industry
How does 84R's PS Ratio compare vs other companies in the DE Real Estate Industry?
| 11 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 3.7x | -11.1% | |
84R Glory Health Industry | 0.3x | n/a | US$75.94m |
DIC Branicks Group | 0.7x | -21.8% | US$194.06m |
DMRE DEMIRE Deutsche Mittelstand Real Estate | 0.5x | -42.0% | US$85.70m |
| 11 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 3.7x | 97.9% | |
84R Glory Health Industry | 0.3x | n/a | US$75.94m |
Price-To-Sales vs Industry: 84R is good value based on its Price-To-Sales Ratio (0.3x) compared to the German Real Estate industry average (3.7x).
Price to Sales Ratio vs Fair Ratio
What is 84R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 84R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Tokyu Fudosan Holdings
JP¥688.6b
Engages in the real estate business in Japan and internationally.
T8F
JP¥5.90
7D
2.6%
1Y
1.7%
Sino Land
HK$67.0b
An investment holding company, invests in, develops, manages, and trades in properties.
SNO
HK$0.94
7D
-0.5%
1Y
0.5%
Relo Group
JP¥259.6b
Engages in the provision of property management services in Japan.
665
JP¥10.50
7D
2.9%
1Y
13.5%